Through years of development, our team has built a comprehensive oncology portfolio that covers the full cycle of cancer management, addressing needs and challenges from early screening, diagnosis & monitoring, and biopharma development services. While continuously carrying out scientific and technological innovation, we efficiently transform these breakthroughs into clinical applications, which have served tens of thousands of patients, and dozens of scientific research institutions and pharmaceutical enterprises across China. See our journey below.



Genetron Health begins strategic partnership with Chia Tai Tianqing (CTTQ) Pharmaceutical Group.


Genetron Health’s early precision lung cancer diagnosis and treatment project, a joint initiative with the West China Hospital of Sichuan University, won the second prize of China’s National Science and Technology Progress Award.


Genetron Health signed a collaboration agreement with AstraZeneca R&D China for the joint development in China of NGS-based tumor-informed (personalized) MRD tests for various solid tumor types.


Laboratory in Maryland is established